Genmab A-S (GMAB) had the highest return between May 1, 2012 and September 1, 2012 by a large-cap US stock, returning 61.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 5/1/2012 - 9/1/2012 | 61.47% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2012 - 9/1/2012 | 61.29% |
Constellation Brands Inc Class A (STZ) | 5/1/2012 - 9/1/2012 | 52.57% |
Madrigal Pharmaceuticals (MDGL) | 5/1/2012 - 9/1/2012 | 51.03% |
New York Times (NYT) | 5/1/2012 - 9/1/2012 | 45.64% |
Royal Gold (RGLD) | 5/1/2012 - 9/1/2012 | 42.12% |
Everpure (P) | 5/1/2012 - 9/1/2012 | 40.56% |
Vertex Pharmaceuticals (VRTX) | 5/1/2012 - 9/1/2012 | 38.88% |
PulteGroup (PHM) | 5/1/2012 - 9/1/2012 | 38.46% |
DexCom (DXCM) | 5/1/2012 - 9/1/2012 | 35.99% |
HF Sinclair (DINO) | 5/1/2012 - 9/1/2012 | 34.86% |
T-Mobile US (TMUS) | 5/1/2012 - 9/1/2012 | 34.02% |
ServiceNow (NOW) | 5/1/2012 - 9/1/2012 | 30.95% |
Charter Communications (CHTR) | 5/1/2012 - 9/1/2012 | 28.83% |
Repligen (RGEN) | 5/1/2012 - 9/1/2012 | 28.73% |
Toll Brothers (TOL) | 5/1/2012 - 9/1/2012 | 28.26% |
Hecla Mining (HL) | 5/1/2012 - 9/1/2012 | 27.42% |
Valero Energy (VLO) | 5/1/2012 - 9/1/2012 | 26.94% |
NRG Energy (NRG) | 5/1/2012 - 9/1/2012 | 26.62% |
Expedia (EXPE) | 5/1/2012 - 9/1/2012 | 26.29% |
Phillips 66 (PSX) | 5/1/2012 - 9/1/2012 | 25.16% |
Walmart (WMT) | 5/1/2012 - 9/1/2012 | 24.66% |
Edwards Lifesciences (EW) | 5/1/2012 - 9/1/2012 | 24.15% |
Five Below (FIVE) | 5/1/2012 - 9/1/2012 | 23.38% |
United Therapeutics (UTHR) | 5/1/2012 - 9/1/2012 | 23.03% |
Large-cap stocks are treated as having a market cap of $10B+.